Characterization of serum HER2 ECD level in patients with metastatic colorectal cancer

被引：0
|
作者：
Taniguchi, H. [1 ]
Hasegawa, H. [2 ]
Masuishi, T. [1 ]
Narita, Y. [1 ]
Komori, A. [1 ]
Kadowaki, S. [1 ]
Ura, T. [3 ]
Muro, K. [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan
[2] Osaka Natl Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan
[3] Aichi Canc Ctr, Nagoya, Aichi 464, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
10.1093/annonc/mdv233.229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-232
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Characterization of serum HER2 extracellular domain (ECD) level in patients with metastatic colorectal cancer
    Hasegawa, Hiroko
    Taniguchi, Hiroya
    Masuishi, Toshiki
    Narita, Yukiya
    Komori, Azusa
    Nomura, Motoo
    Kadowaki, Shigenori
    Andoh, Masashi
    Ura, Takashi
    Muro, Kei
    ANNALS OF ONCOLOGY, 2015, 26 : 116 - 116
  • [2] Serial measurement of serum extracellular domain of HER2 (ECD/HER2) has prognostic value in metastatic breast cancer.
    Bramwell, V. H. C.
    Doig, G. S.
    Tuck, A. B.
    Wilson, S. M.
    Tonkin, K. S.
    Tomiak, A.
    Perera, F.
    Vandenberg, T. A.
    Chambers, A. F.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S40 - S40
  • [3] Correlation between serum HER2 extracellular domain (HER2 ECD) levels and tumour size in early, advanced and metastatic breast cancer with HER2 overexpression
    Makino, H.
    Tengan, H.
    Tatsuda, K.
    Hashidate, H.
    Mio, K.
    Kiguchi, T.
    Yamazaki, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S114 - S115
  • [4] Serum level of HER2 extra cellular domain (ECD) is a significant prognostic factor for survival in metastatic breast cancer without HER2 overexpression on primary tumor.
    Dinocca, S.
    Blot, E.
    Laberge-Le-Couteulx, S.
    Menard, J.-F.
    Guillemet, C.
    Veyret, C.
    Basuyau, J.-P.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S50 - S50
  • [5] Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer
    Vivien H. C. Bramwell
    Gordon S. Doig
    Alan B. Tuck
    Sylvia M. Wilson
    Katia S. Tonkin
    Anna Tomiak
    Francisco Perera
    Theodore A. Vandenberg
    Ann F. Chambers
    Breast Cancer Research and Treatment, 2009, 114
  • [6] Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer
    Bramwell, Vivien H. C.
    Doig, Gordon S.
    Tuck, Alan B.
    Wilson, Sylvia M.
    Tonkin, Katia S.
    Tomiak, Anna
    Perera, Francisco
    Vandenberg, Theodore A.
    Chambers, Ann F.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 503 - 511
  • [7] Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer
    Kong, Sun-Young
    Nam, Byung-Ho
    Lee, Keun Seok
    Kwon, Youngmee
    Lee, Eun Sook
    Seong, Moon-Woo
    Lee, Do Hoon
    Ro, Jungsil
    CLINICAL CHEMISTRY, 2006, 52 (08) : 1510 - 1515
  • [8] Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer
    Sawada, Kentaro
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Kuboki, Yasutoshi
    Yamaguchi, Daisuke
    Yuki, Satoshi
    Yoshino, Takayuki
    Komatsu, Yoshito
    Sakamoto, Naoya
    Okamoto, Wataru
    Fujii, Satoshi
    CLINICAL COLORECTAL CANCER, 2018, 17 (03) : 198 - 205
  • [9] Circulating HER2 extracellular domain (ECD) predicts a poor prognosis for metastatic breast cancer patients
    Wang, X-J
    Shao, X-Y
    Xu, X-H
    Chen, Z-H
    Wang, S.
    Cai, J-F
    Huang, J.
    Huang, P.
    Lou, C-J
    Ling, Z-Q
    Han, M. X.
    CANCER RESEARCH, 2012, 72
  • [10] Serum HER2 extracellular domain as a potential alternative for tissue HER2 status in metastatic gastric cancer patients
    Peng, Zhi
    Liu, Yi
    Li, Yanyan
    Zhang, Xiaotian
    Zhou, Jun
    Lu, Ming
    Li, Qingqing
    Shen, Lin
    BIOMARKERS IN MEDICINE, 2014, 8 (05) : 663 - 670
12345